BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26647369)

  • 1. Mapping proteome-wide interactions of reactive chemicals using chemoproteomic platforms.
    Counihan JL; Ford B; Nomura DK
    Curr Opin Chem Biol; 2016 Feb; 30():68-76. PubMed ID: 26647369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping Proteome-Wide Targets of Environmental Chemicals Using Reactivity-Based Chemoproteomic Platforms.
    Medina-Cleghorn D; Bateman LA; Ford B; Heslin A; Fisher KJ; Dalvie ED; Nomura DK
    Chem Biol; 2015 Oct; 22(10):1394-405. PubMed ID: 26496688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Drug Mechanism of Action by Proteome Wide- Identification of Drug-Binding Proteins.
    Cui T; Hou H; Sun Y; Cang H; Wang X
    Med Chem; 2017; 13(6):526-535. PubMed ID: 28523998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoproteomic-enabled phenotypic screening.
    Conway LP; Li W; Parker CG
    Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based chemoproteomic approaches.
    Bantscheff M
    Methods Mol Biol; 2012; 803():3-13. PubMed ID: 22065214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoproteomic profiling of protein modifications by lipid-derived electrophiles.
    Chen Y; Qin W; Wang C
    Curr Opin Chem Biol; 2016 Feb; 30():37-45. PubMed ID: 26625013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoproteomic profiling of protein-metabolite interactions.
    Qin W; Yang F; Wang C
    Curr Opin Chem Biol; 2020 Feb; 54():28-36. PubMed ID: 31812894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing small molecule-protein interactions: A new perspective for functional proteomics.
    Lenz T; Fischer JJ; Dreger M
    J Proteomics; 2011 Dec; 75(1):100-15. PubMed ID: 21835278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based proteomics in preclinical drug discovery.
    Schirle M; Bantscheff M; Kuster B
    Chem Biol; 2012 Jan; 19(1):72-84. PubMed ID: 22284356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.
    Browne CM; Jiang B; Ficarro SB; Doctor ZM; Johnson JL; Card JD; Sivakumaren SC; Alexander WM; Yaron TM; Murphy CJ; Kwiatkowski NP; Zhang T; Cantley LC; Gray NS; Marto JA
    J Am Chem Soc; 2019 Jan; 141(1):191-203. PubMed ID: 30518210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target profiling of small molecules by chemical proteomics.
    Rix U; Superti-Furga G
    Nat Chem Biol; 2009 Sep; 5(9):616-24. PubMed ID: 19690537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of direct protein targets of small molecules.
    Lomenick B; Olsen RW; Huang J
    ACS Chem Biol; 2011 Jan; 6(1):34-46. PubMed ID: 21077692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in microarray technologies for proteomics.
    Sun H; Chen GY; Yao SQ
    Chem Biol; 2013 May; 20(5):685-99. PubMed ID: 23706635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication.
    Piazza I; Kochanowski K; Cappelletti V; Fuhrer T; Noor E; Sauer U; Picotti P
    Cell; 2018 Jan; 172(1-2):358-372.e23. PubMed ID: 29307493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology analysis of protein-drug interactions.
    Colinge J; Rix U; Bennett KL; Superti-Furga G
    Proteomics Clin Appl; 2012 Jan; 6(1-2):102-16. PubMed ID: 22213655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.
    Roberts AM; Miyamoto DK; Huffman TR; Bateman LA; Ives AN; Akopian D; Heslin MJ; Contreras CM; Rape M; Skibola CF; Nomura DK
    ACS Chem Biol; 2017 Apr; 12(4):899-904. PubMed ID: 28186401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted and proteome-wide analysis of metabolite-protein interactions.
    Tsukidate T; Li Q; Hang HC
    Curr Opin Chem Biol; 2020 Feb; 54():19-27. PubMed ID: 31790852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.